Clinical Trial Update: A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic transplant in pediatric hematologic malignancies. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Biphenotypic Leukemia
• Chronic Myeloid Leukemia
• Juvenile Myelomonocytic Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: University of California, San Francisco | Conditions: Acute Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-10-31